CA Stock MarketDetailed Quotes

GUD Knight Therapeutics Inc

Watchlist
  • 5.300
  • +0.090+1.73%
15min DelayMarket Closed Nov 21 16:00 ET
534.25MMarket Cap-18275P/E (TTM)

Knight Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
13.21%92.26M
6.30%95.57M
4.85%86.6M
11.80%328.2M
-9.13%74.2M
12.75%81.5M
18.58%89.91M
29.45%82.6M
20.57%293.56M
40.12%81.66M
Operating revenue
13.21%92.26M
6.30%95.57M
4.85%86.6M
11.80%328.2M
-9.13%74.2M
12.75%81.5M
18.58%89.91M
29.45%82.6M
20.57%293.56M
40.12%81.66M
Cost of revenue
14.35%47.25M
-7.97%48.24M
7.34%44.91M
12.89%175.55M
-10.69%39.98M
-1.34%41.32M
39.67%52.41M
33.53%41.84M
21.42%155.5M
48.84%44.77M
Gross profit
12.03%45.02M
26.26%47.34M
2.30%41.7M
10.57%152.65M
-7.25%34.22M
32.17%40.18M
-2.09%37.49M
25.51%40.76M
19.62%138.06M
30.83%36.89M
Operating expense
6.53%41.81M
13.94%42.84M
11.13%39.04M
-5.70%146.28M
-25.49%34.3M
-2.69%39.25M
4.57%37.6M
7.12%35.13M
20.96%155.12M
7.48%46.03M
Selling and administrative expenses
10.77%25.48M
15.32%25.36M
17.28%23.19M
-5.56%83.69M
-23.50%18.93M
-3.64%23M
2.33%21.99M
6.74%19.77M
19.16%88.62M
10.97%24.74M
-Selling and marketing expense
12.14%13.37M
3.03%13.26M
18.60%12.65M
-4.53%46.28M
-24.90%10.82M
-11.39%11.92M
17.83%12.87M
10.06%10.67M
24.04%48.47M
17.18%14.4M
-General and administrative expense
9.30%12.11M
32.68%12.1M
15.73%10.54M
-6.81%37.41M
-21.55%8.11M
6.37%11.08M
-13.69%9.12M
3.10%9.11M
13.75%40.15M
3.34%10.34M
Research and development costs
8.07%5.15M
33.90%5.81M
18.94%4.98M
18.94%17.55M
2.85%4.26M
12.99%4.77M
27.08%4.34M
40.36%4.19M
16.25%14.76M
18.42%4.14M
Depreciation amortization depletion
-2.62%11.18M
3.55%11.67M
-2.68%10.87M
-12.95%45.04M
-35.21%11.12M
-6.23%11.48M
1.98%11.27M
-1.04%11.17M
25.66%51.74M
0.68%17.16M
-Depreciation and amortization
-2.62%11.18M
3.55%11.67M
-2.68%10.87M
-12.95%45.04M
-35.21%11.12M
-6.23%11.48M
1.98%11.27M
-1.04%11.17M
25.66%51.74M
0.68%17.16M
Operating profit
244.41%3.2M
4,185.45%4.49M
-52.78%2.66M
137.34%6.37M
99.09%-83K
109.36%930K
-104.71%-110K
1,882.59%5.63M
-32.95%-17.06M
37.50%-9.15M
Net non-operating interest income (expenses)
34.51%608K
261.45%300K
-88.59%64K
-97.84%87K
-151.22%-1.01M
-54.02%452K
-88.31%83K
52.03%561K
7.12%4.03M
127.75%1.97M
Non-operating interest income
-17.41%2.52M
-16.29%2.58M
-21.21%2.64M
18.28%12.58M
-27.73%3.08M
24.09%3.06M
27.19%3.09M
126.49%3.35M
44.03%10.63M
94.13%4.26M
Non-operating interest expense
-26.43%1.92M
-23.97%2.28M
-7.67%2.58M
89.21%12.49M
78.37%4.09M
76.00%2.6M
74.96%3M
151.22%2.79M
82.42%6.6M
72.28%2.29M
Other net income (expenses)
-142.62%-3.2M
-1,807.53%-4.08M
11.42%-9.87M
8.04%-28.45M
-57.03%-25.06M
-23.32%7.52M
109.92%239K
50.19%-11.14M
-296.29%-30.93M
-2,336.49%-15.96M
Gain on sale of security
-221.22%-5.15M
-534.01%-6.21M
-21.73%-14.33M
-91.86%-25.39M
-335.79%-16.89M
-20.52%4.25M
69.26%-979K
47.79%-11.77M
-187.03%-13.24M
704.30%7.16M
Special income (charges)
-15.84%1.15M
129.52%2.08M
490.11%4.3M
72.58%-5.96M
57.66%-8.96M
197.50%1.36M
63.31%908K
162.82%728K
-5,235.22%-21.72M
-10,222.49%-21.16M
-Less:Impairment of capital assets
----
----
----
-61.39%9.26M
----
----
----
----
--23.98M
--21.9M
-Less:Other special charges
15.84%-1.15M
-129.52%-2.08M
-490.11%-4.3M
-46.02%-3.3M
59.49%-303K
-100.29%-1.36M
-63.31%-908K
-162.82%-728K
-434.75%-2.26M
-257.89%-748K
Other non-operating income (expenses)
-58.31%795K
-86.45%42K
279.79%169K
-27.83%2.91M
139.82%782K
-67.46%1.91M
41.55%310K
-4.44%-94K
3,044.53%4.03M
-711.84%-1.96M
Income before tax
-93.17%608K
236.32%713K
-44.44%-7.14M
49.98%-21.99M
-13.04%-26.15M
945.59%8.9M
-66.67%212K
77.83%-4.95M
-757.10%-43.96M
-60.39%-23.14M
Income tax
175.80%523K
263.08%2.66M
-157.48%-2.6M
63.37%-5.15M
77.02%-1.83M
6.76%-690K
13.40%-1.63M
71.18%-1.01M
-56.57%-14.07M
-29.79%-7.95M
Earnings from equity interest net of tax
Net income
-99.11%85K
-205.54%-1.94M
-15.47%-4.55M
43.68%-16.84M
-60.17%-24.33M
502.64%9.59M
-26.87%1.84M
79.07%-3.94M
-290.70%-29.89M
-82.97%-15.19M
Net income continuous operations
-99.11%85K
-205.54%-1.94M
-15.47%-4.55M
43.68%-16.84M
-60.17%-24.33M
502.64%9.59M
-26.87%1.84M
79.07%-3.94M
-290.70%-29.89M
-82.97%-15.19M
Noncontrolling interests
Net income attributable to the company
-99.11%85K
-205.54%-1.94M
-15.47%-4.55M
43.68%-16.84M
-60.17%-24.33M
502.64%9.59M
-26.87%1.84M
79.07%-3.94M
-290.70%-29.89M
-82.97%-15.19M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-99.11%85K
-205.54%-1.94M
-15.47%-4.55M
43.68%-16.84M
-60.17%-24.33M
502.64%9.59M
-26.87%1.84M
79.07%-3.94M
-290.70%-29.89M
-82.97%-15.19M
Diluted earnings per share
-99.07%0.0008
-200.00%-0.02
0.00%-0.04
38.46%-0.16
-76.92%-0.23
800.00%0.09
0.00%0.02
75.00%-0.04
-300.00%-0.26
-116.67%-0.13
Basic earnings per share
-99.07%0.0008
-200.00%-0.02
0.00%-0.04
38.46%-0.16
-76.92%-0.23
800.00%0.09
0.00%0.02
75.00%-0.04
-300.00%-0.26
-116.67%-0.13
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 13.21%92.26M6.30%95.57M4.85%86.6M11.80%328.2M-9.13%74.2M12.75%81.5M18.58%89.91M29.45%82.6M20.57%293.56M40.12%81.66M
Operating revenue 13.21%92.26M6.30%95.57M4.85%86.6M11.80%328.2M-9.13%74.2M12.75%81.5M18.58%89.91M29.45%82.6M20.57%293.56M40.12%81.66M
Cost of revenue 14.35%47.25M-7.97%48.24M7.34%44.91M12.89%175.55M-10.69%39.98M-1.34%41.32M39.67%52.41M33.53%41.84M21.42%155.5M48.84%44.77M
Gross profit 12.03%45.02M26.26%47.34M2.30%41.7M10.57%152.65M-7.25%34.22M32.17%40.18M-2.09%37.49M25.51%40.76M19.62%138.06M30.83%36.89M
Operating expense 6.53%41.81M13.94%42.84M11.13%39.04M-5.70%146.28M-25.49%34.3M-2.69%39.25M4.57%37.6M7.12%35.13M20.96%155.12M7.48%46.03M
Selling and administrative expenses 10.77%25.48M15.32%25.36M17.28%23.19M-5.56%83.69M-23.50%18.93M-3.64%23M2.33%21.99M6.74%19.77M19.16%88.62M10.97%24.74M
-Selling and marketing expense 12.14%13.37M3.03%13.26M18.60%12.65M-4.53%46.28M-24.90%10.82M-11.39%11.92M17.83%12.87M10.06%10.67M24.04%48.47M17.18%14.4M
-General and administrative expense 9.30%12.11M32.68%12.1M15.73%10.54M-6.81%37.41M-21.55%8.11M6.37%11.08M-13.69%9.12M3.10%9.11M13.75%40.15M3.34%10.34M
Research and development costs 8.07%5.15M33.90%5.81M18.94%4.98M18.94%17.55M2.85%4.26M12.99%4.77M27.08%4.34M40.36%4.19M16.25%14.76M18.42%4.14M
Depreciation amortization depletion -2.62%11.18M3.55%11.67M-2.68%10.87M-12.95%45.04M-35.21%11.12M-6.23%11.48M1.98%11.27M-1.04%11.17M25.66%51.74M0.68%17.16M
-Depreciation and amortization -2.62%11.18M3.55%11.67M-2.68%10.87M-12.95%45.04M-35.21%11.12M-6.23%11.48M1.98%11.27M-1.04%11.17M25.66%51.74M0.68%17.16M
Operating profit 244.41%3.2M4,185.45%4.49M-52.78%2.66M137.34%6.37M99.09%-83K109.36%930K-104.71%-110K1,882.59%5.63M-32.95%-17.06M37.50%-9.15M
Net non-operating interest income (expenses) 34.51%608K261.45%300K-88.59%64K-97.84%87K-151.22%-1.01M-54.02%452K-88.31%83K52.03%561K7.12%4.03M127.75%1.97M
Non-operating interest income -17.41%2.52M-16.29%2.58M-21.21%2.64M18.28%12.58M-27.73%3.08M24.09%3.06M27.19%3.09M126.49%3.35M44.03%10.63M94.13%4.26M
Non-operating interest expense -26.43%1.92M-23.97%2.28M-7.67%2.58M89.21%12.49M78.37%4.09M76.00%2.6M74.96%3M151.22%2.79M82.42%6.6M72.28%2.29M
Other net income (expenses) -142.62%-3.2M-1,807.53%-4.08M11.42%-9.87M8.04%-28.45M-57.03%-25.06M-23.32%7.52M109.92%239K50.19%-11.14M-296.29%-30.93M-2,336.49%-15.96M
Gain on sale of security -221.22%-5.15M-534.01%-6.21M-21.73%-14.33M-91.86%-25.39M-335.79%-16.89M-20.52%4.25M69.26%-979K47.79%-11.77M-187.03%-13.24M704.30%7.16M
Special income (charges) -15.84%1.15M129.52%2.08M490.11%4.3M72.58%-5.96M57.66%-8.96M197.50%1.36M63.31%908K162.82%728K-5,235.22%-21.72M-10,222.49%-21.16M
-Less:Impairment of capital assets -------------61.39%9.26M------------------23.98M--21.9M
-Less:Other special charges 15.84%-1.15M-129.52%-2.08M-490.11%-4.3M-46.02%-3.3M59.49%-303K-100.29%-1.36M-63.31%-908K-162.82%-728K-434.75%-2.26M-257.89%-748K
Other non-operating income (expenses) -58.31%795K-86.45%42K279.79%169K-27.83%2.91M139.82%782K-67.46%1.91M41.55%310K-4.44%-94K3,044.53%4.03M-711.84%-1.96M
Income before tax -93.17%608K236.32%713K-44.44%-7.14M49.98%-21.99M-13.04%-26.15M945.59%8.9M-66.67%212K77.83%-4.95M-757.10%-43.96M-60.39%-23.14M
Income tax 175.80%523K263.08%2.66M-157.48%-2.6M63.37%-5.15M77.02%-1.83M6.76%-690K13.40%-1.63M71.18%-1.01M-56.57%-14.07M-29.79%-7.95M
Earnings from equity interest net of tax
Net income -99.11%85K-205.54%-1.94M-15.47%-4.55M43.68%-16.84M-60.17%-24.33M502.64%9.59M-26.87%1.84M79.07%-3.94M-290.70%-29.89M-82.97%-15.19M
Net income continuous operations -99.11%85K-205.54%-1.94M-15.47%-4.55M43.68%-16.84M-60.17%-24.33M502.64%9.59M-26.87%1.84M79.07%-3.94M-290.70%-29.89M-82.97%-15.19M
Noncontrolling interests
Net income attributable to the company -99.11%85K-205.54%-1.94M-15.47%-4.55M43.68%-16.84M-60.17%-24.33M502.64%9.59M-26.87%1.84M79.07%-3.94M-290.70%-29.89M-82.97%-15.19M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -99.11%85K-205.54%-1.94M-15.47%-4.55M43.68%-16.84M-60.17%-24.33M502.64%9.59M-26.87%1.84M79.07%-3.94M-290.70%-29.89M-82.97%-15.19M
Diluted earnings per share -99.07%0.0008-200.00%-0.020.00%-0.0438.46%-0.16-76.92%-0.23800.00%0.090.00%0.0275.00%-0.04-300.00%-0.26-116.67%-0.13
Basic earnings per share -99.07%0.0008-200.00%-0.020.00%-0.0438.46%-0.16-76.92%-0.23800.00%0.090.00%0.0275.00%-0.04-300.00%-0.26-116.67%-0.13
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data